Travis Coy
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Travis Coy
Travis Coy is recorded as CFO at Immunocore Holdings plc (IMCR). Immunocore Holdings plc reported in an 8-K filed January 2, 2025 that Travis Coy resigned as board of directors, effective January 1, 2025. Immunocore Holdings plc reported in an 8-K filed January 2, 2025 that Travis Coy was appointed Executive Vice President, Chief Financial Officer and Head of Corporate Development, effective January 1, 2025. The proxy statement of Immunocore Holdings plc reports total compensation of $5,171,209 for Travis Coy in fiscal 2025, including a base salary of $500,000. Travis Coy has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for Immunocore Holdings plc on April 13, 2026.
“In connection with his entry into the Employment Agreement, Mr. Coy resigned from the Company’s board of directors (the “Board”), effective as of the Effective Date.”
“On December 31, 2024, Immunocore LLC, an indirect, wholly owned subsidiary of Immunocore Holdings plc (“Parent” and, together with Immunocore LLC, the “Company”), entered into an employment agreement (the “Employment Agreement”) with Travis Coy, pursuant to which Mr. Coy will serve as the Company’s Executive Vice President, Chief Financial Officer and Head of Corporate Development as well as the Company’s principal financial officer, effective as of January 1, 2025 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2025-01-01
-
Start not stated–2025-01-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunocore Holdings plc
Other people whose current roles at this company are on record from its filings.
- Bahija Jallal CEO, Board Member
- Professor Sir John Bell Chairman
- Kristine Peterson Board Member
- Professor Sir Peter Ratcliffe Board Member
- Ranjeev Krishana Board Member
- Roy S. Herbst Board Member
- Siddharth Kaul Board Member
- William Pao Board Member
- William Pao, M.D., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Immunocore Holdings plc (IMCR) | Chief Financial Officer | $500,000 | $5,171,209 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.